DRD2 encodes dopamine receptor D2 and the binding ofdopaminergic agents such as bromocriptine to dopamine receptors is used to treatT2D symptoms including hyperglycemia, insulin resistance, free fatty acids, andTG [62]. The gene discussed is DRD2; the disease is Insulin resistance.